Lv61
2730 积分 2022-05-26 加入
巴金森氏症的治療與最新藥物進展
4小时前
求助中
Effectiveness of Zonisamide Prophylaxis in Reducing Headache Days per Month for Pediatric Patients with Migraine Disease, A Retrospective Analysis (P11-6.017)
16天前
已关闭
唑尼沙胺治疗新近确诊为部分性癫痫患者的疗效和耐受性不劣于卡马西平
17天前
已完结
Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
17天前
已完结
Evaluation and Management of First-Time Seizure in Adults
1个月前
已完结
Trends in the Burden of Epilepsy in China from 1990 to 2021 and Its Forecast until 2044: Based on the 2021 Global Burden of Disease Study
1个月前
已完结
Review article: potassium‐competitive acid blockers for the treatment of acid‐related disorders
1个月前
已完结
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities
1个月前
已完结
Advances in the Management of Acute and Recurrent Urinary Tract Infections Caused by Resistant Pathogens – What’s Next?
2个月前
已完结
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2个月前
已完结
皖公网安备34019202002308
